Zeng Fang

802 citations
23 papers · 621 indexed · h-index 11
Topics
Cancer-related molecular mechanisms research (7 papers)MicroRNA in disease regulation (6 papers)RNA modifications and cancer (6 papers)
Partner nations
ChinaUnited StatesRussia

In The Last Decade

Zeng Fang

23 papers receiving 615 citations

Peers

Zeng Fang
Comparison fields: 5 of 69
  • Molecular Biology 511
  • Cancer Research 428
  • Oncology 61
  • Immunology 45
  • Pulmonary and Respiratory Medicine 42
Replace Jeff Bruce with:
Jeff Bruce Canada
Asaf Shilo Israel
Yuxi Ou China
Marco Pieraccioli Italy
C-G Liu China
Jiadong Wang China
Sujin Yim South Korea
Simon Grelet United States
Xuegang Guo China
Zeng Fang relative to Jeff Bruce Canada Jeff Bruce's profile →
Citations per field
00.5×1.5×1.9×
Jeff Bruce · 1×
Citations per year

Countries citing papers authored by Zeng Fang

Since Specialization
Citations

This map shows the geographic impact of Zeng Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeng Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeng Fang more than expected).

Fields of papers citing papers by Zeng Fang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeng Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeng Fang. The network helps show where Zeng Fang may publish in the future.

Co-authorship network of co-authors of Zeng Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Zeng Fang. A scholar is included among the top collaborators of Zeng Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeng Fang. Zeng Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 5
3 5
4 3
5 11
6 16
7 8
8 1
9 6
10 8
11 28
12 2
13 18
14 17
15 208
16
[Expression and prognostic value of vacuole membrane protein 1 in non-small-cell lung cancer].
1
17 70
18 83
19 59
20
Empirical Study on Pathological Change and TCM Syndrome Differentiation Intervention of Liver Mitochondria in NAFLD
1

About Zeng Fang

Zeng Fang is a scholar working on Cancer Research, Molecular Biology and Genetics, having authored 23 papers that have together received 621 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (6 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (428 citations), Molecular Biology (511 citations) and Oncology (61 citations). Zeng Fang has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Yanyan Huang, Lina Ma, Wangyu Zhu, Shiquan Zhou, Yongkui Zhang, Jihang Zhou, Yekai Wang, Xiaoguang Liu, Minghua Wu and Guiyuan Li. Their work appears in journals such as PLoS ONE, Cancer Research and Brain Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026